Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?

Autor: Kim E; College of Medicine, University of Central Florida., Do T; College of Medicine, University of Central Florida., Peacock K; College of Medicine, University of Central Florida., Takundwa PT; College of Medicine, University of Central Florida.

Publikováno v: Cureus [Cureus] 2016 Sep 01; Vol. 8 (9), pp. e765. Date of Electronic Publication: 2016 Sep 01.

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report.

Autor: Skride, Andris^1,2, Sablinskis, Matiss¹, Sablinskis, Kristaps^1,2, Lejniece, Sandra^1,3, Lejnieks, Aivars^1,4, Klepetko, Walter⁵, Lang, Irene M.⁶ irene.lang@meduniwien.ac.at

Publikováno v: American Journal of Case Reports. 10/19/2018, Vol. 19, p1245-1248. 4p.

The effect of vitamin D levels on gastrointestinal bleeding in patients with warfarin therapy.

Autor: Keskin, Ümran, Basat, Sema

Publikováno v: Blood Coagulation & Fibrinolysis; Oct2019, Vol. 30 Issue 7, p331-336, 6p

THE UTILITY OF INTERNATIONAL NORMALIZED RATIO MONITORING IN ANTIPHOPHOLIPID SYNDROME AND LUPUS ANTICOAGULANT.

Autor: Leys, Lorenzo, Kalu, Ifunanya, Donaldson, Sahai, Thomas, Alicia

Publikováno v: CHEST; 2020 Supplement, Vol. 158, pA2308-A2308, 1p